It is upregulated in glioma and promotes glioma cell proliferation and migration by increasing the sumoylation and phosphorylation of protein kinase B (PKB/AKT), leading to glioma development in vitro and in vivo [11]. This evidence concerns the gene AKT1 and central nervous system cancer.